U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT06958107) titled 'LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma Patients' on April 27.

Brief Summary: The purpose of this research study is to see how well Low Pass Whole Genome Sequencing (LP-WGS) can detect circulating tumor deoxyribonucleic acid (ctDNA) in the blood of participants who have bone or soft tissue sarcoma (type of cancer).

Study Start Date: June, 2025

Study Type: OBSERVATIONAL

Condition: Sarcoma

Intervention: OTHER: Non-Metastatic and Resectable

Blood Draw Timepoints:

* Before any treatment begins

* After Neo-adjuvant therapy (only if you receive this type of therapy)

* After local surgery

* After Adj...